India presently represents 3-4% of global biosimilar production, second to China and aims to increase it significantly. With ...

The Centers for Medicare & Medicaid Services is attempting to cover anti-obesity medications under Medicare Part D and ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

Zydus Lifesciences is exploring mergers, acquisitions, and licensing to bolster its specialty portfolio in the US, ...

Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. Receive News & Ratings for Orion Oyj ...

HYDERABAD: Inaugurating the Indo-Belgian Life Sciences Conference in Hyderabad, Industries Minister D Sridhar Babu on Tuesday ...

Integrating IT with pharmaceuticals will further strengthen its role, paving the way for dominance in biologics and ...

The growing inclination for biologics and biosimilars is driving the sterile injectable contract manufacturing market.New ...

Chronic ocular pain market is poised for significant growth, fueled by increasing awareness, innovative treatments, and a ...

Hyderabad's role in India-Belgium Life Sciences partnership highlighted by Industries Minister, emphasizing collaboration for ...

The Centers for Medicare & Medicaid Services Nov. 26 proposed changes to increase oversight of the Medicare Advantage and prescription drug programs for contract year 2026.